Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience

1Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306. 10.1056/NEJM199801293380506TableSchlumbergerMJ.Papillary and follicular thyroid carcinomaN Engl J Med199833829730610.1056/NEJM199801293380506TableOpen DOISearch in Google Scholar

2Chow SM, Law SCK, Mendenhall WM, Au SK, Chan PT, Leung TW, et al. Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys 2002; 52: 784-95. org/10.1016/S0360-3016(01)02686-4TableChowSMLawSCKMendenhallWMAuSKChanPTLeungTWPapillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapyInt J Radiat Oncol Biol Phys20025278495org/10.1016/S0360-3016(01)02686-4TableOpen DOISearch in Google Scholar

3Brierley J, Tsang R, Panzarella T, Bana N. Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years. Clin Endocrinol (Oxf) 2005; 63: 418-27. 10.1111/j.1365-2265.2005.02358.xTableBrierleyJTsangRPanzarellaTBanaN.Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 yearsClin Endocrinol (Oxf)2005634182710.1111/j.1365-2265.2005.02358.xTableOpen DOISearch in Google Scholar

4Kim JH, Leeper RD. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 1987; 60: 2372-5. TableKimJHLeeperRD.Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapyCancer1987602372510.1002/1097-0142(19871115)60:10<2372::AID-CNCR2820601004>3.0.CO;2-1Search in Google Scholar

5Philips P, Hansen C, Andry G, Van Houtte P, Früuling J. Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 1993; 19: 399-404.TablePhilipsPHansenCAndryGVan HouttePFrüulingJ.Postoperative irradiation for thyroid cancerEur J Surg Oncol199319399404TableSearch in Google Scholar

6Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996; 77: 172-80. 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1TableFarahatiJReinersCStuschkeMMüller SP StübenGSauerweinWSackH.Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)Cancer1996771728010.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1TableOpen DOISearch in Google Scholar

7Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998; 82: 375-88 .TableTsangRWBrierleyJDSimpsonWJPanzarellaTGospodarowiczMKSutcliffeSB.The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinomaCancer19988237588Table10.1002/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-VSearch in Google Scholar

8Rosenbluth BD, Serrano V, Happersett L, Shaha AR, Tuttle RM, Narayana A, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1419-26. 10.1016/j.ijrobp.2005.05.043TableRosenbluthBDSerranoVHappersettLShahaARTuttleRMNarayanaAIntensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancerInt J Radiat Oncol Biol Phys20056314192610.1016/j.ijrobp.2005.05.043TableOpen DOISearch in Google Scholar

9Chow SM, Yau S, Kwan CK, Poon PC, Law SC. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. Endocr Relat Cancer 2006; 13: 1159-72. 10.1677/erc.1.01320TableChowSMYauSKwanCKPoonPCLawSC.Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th editionEndocr Relat Cancer20061311597210.1677/erc.1.01320TableOpen DOISearch in Google Scholar

10Azrif M, Slevin NJ, Sykes AJ, Swindell R, Yap BK. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol 2008; 89: 105-13. 10.1016/j.radonc.2008.05.023TableAzrifMSlevinNJSykesAJSwindellRYapBK.Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineationRadiother Oncol2008891051310.1016/j.radonc.2008.05.023TableOpen DOISearch in Google Scholar

11Terezakis SA, Lee KS, Ghossein RA, Rivera M, Tuttle RM, Wolden SL, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2009; 73: 795-801. 10.1016/j.ijrobp.2008.05.012TableTerezakisSALeeKSGhosseinRARiveraMTuttleRMWoldenSLRole of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experienceInt J Radiat Oncol Biol Phys20097379580110.1016/j.ijrobp.2008.05.012TableOpen DOISearch in Google Scholar

12Schwartz DL, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Ahamad A, et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 2009; 74: 1083-91. 10.1016/j.ijrobp.2008.09.023TableSchwartzDLLoboMJAngKKMorrisonWHRosenthalDIAhamadAPostoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatmentInt J Radiat Oncol Biol Phys20097410839110.1016/j.ijrobp.2008.09.023TableOpen DOISearch in Google Scholar

13Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, et al; MSDS study group. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial. Nuklearmedizin 2009; 48: 89-98. 10.3413/nukmed-0221TableBiermannMPixbergMRiemannBSchuckAHeineckeASchmidKWMSDS study group. Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trialNuklearmedizin200948899810.3413/nukmed-0221TableOpen DOISearch in Google Scholar

14Kim TH, Chung KW, Lee YJ, Park CS, Lee EK, Kim TS, et al. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer. Radiat Oncol 2010; 5: 69. 10.1186/1748-717X-5-69TableKimTHChungKWLeeYJParkCSLeeEKKimTSThe effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancerRadiat Oncol201056910.1186/1748-717X-5-69TableOpen DOISearch in Google Scholar

15Cancer in Slovenia 2014. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia, 2017. [cited 2018 April 15]. Available from: https://www.onko-i.si/filead-min/onko/datoteke/dokumenti/RRS/LP_2014.pdfTableCancer in Slovenia 2014Ljubljana: Institute of Oncology LjubljanaEpidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia2017[cited 2018 April 15]. Available fromhttps://www.onko-i.si/filead-min/onko/datoteke/dokumenti/RRS/LP_2014.pdfTableSearch in Google Scholar

16Rosai J. Tumors of thyroid gland. In: Rosai J, Carcangiu ML, DeLellis RA, editors. Atlas of tumor pathology. Washington: Armed Forces Institute of Pathology; 1992. p. 31-50.TableRosaiJ.Tumors of thyroid glandRosaiJCarcangiuMLDeLellisRAeditors. Atlas of tumor pathology.Washington: Armed Forces Institute of Pathology19923150TableSearch in Google Scholar

17LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol 2004; 11: 279-87. 10.1097/01.pap.0000138143.34505.02TableLiVolsiVABalochZW.Follicular neoplasms of the thyroid: view, biases, and experiencesAdv Anat Pathol2004112798710.1097/01.pap.0000138143.34505.02TableOpen DOISearch in Google Scholar

18Sobin LH, Gospodarowicz MK, Wittekind C. Thyroid gland (ICD-O C73). In: Sobin LH, Gospodarowicz MK, Witekind C, editors. TNM classification of malignant tumours. 7th Edition. New York: Wiley Blackwell; 2009. p. 58-62. TableSobinLHGospodarowiczMKWittekindC.Thyroid gland (ICD-O C73)SobinLHGospodarowiczMKWitekindCeditorsTNM classification of malignant tumours.7th EditionNew York: Wiley Blackwell20095862Table10.1002/9780471420194.tnmc08.pub2Search in Google Scholar

19Zagar I, Schwarzbartl-Pevec A, Vidergar-Kralj B, Horvat R, Besic N. Recombinant human thyrotropin-aided radioiodine therapy in patients with metastatic differentiated thyroid carcinoma. J Thyroid Res 2012; 670180. 10.1155/2012/670180TableZagarISchwarzbartl-PevecAVidergar-KraljBHorvatRBesicN.Recombinant human thyrotropin-aided radioiodine therapy in patients with metastatic differentiated thyroid carcinomaJ Thyroid Res201267018010.1155/2012/670180TableOpen DOISearch in Google Scholar

20Vassilopoulou-Sellin R, Schultz PN, Haynie TP. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Cancer 1996; 78: 493-501. 10.1002/(SICI)1097-0142(19960801)78:3<493::AID-CNCR17>3.0.CO;2-UTableVassilopoulou-SellinRSchultzPNHaynieTP.Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapyCancer19967849350110.1002/(SICI)1097-0142(19960801)78:3<493::AID-CNCR17>3.0.CO;2-UTableOpen DOISearch in Google Scholar

21Feig BW, Ching DC editors. The MD Anderson surgical oncology handbook. Philadelphia: Lippincott Williams & Wilkins; 2012.TableFeigBWChing DC editorsThe MD Anderson surgical oncology handbook.Philadelphia: Lippincott Williams & Wilkins2012TableSearch in Google Scholar

22Santini F, Bottici V, Elisei R, Montanelli L, Mazzeo S, Basolo F, et al. Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly-differentiated thyroid cancer. J Clin Endocrinol Metab 2002; 87: 4160-5. 10.1210/jc.2001-011151TableSantiniFBotticiVEliseiRMontanelliLMazzeoSBasoloFCytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly-differentiated thyroid cancerJ Clin Endocrinol Metab2002874160510.1210/jc.2001-011151TableOpen DOISearch in Google Scholar

23Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016; 26: 1-133. 10.1089/thy.2015.0020TableHaugenBRAlexanderEKBibleKCDohertyGMMandelSJNikiforovYE2015American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid201626113310.1089/thy.2015.0020TableOpen DOISearch in Google Scholar

24Brierley JD. Update on external beam radiation therapy in thyroid cancer. J Clin Endocrinol Metab 2011; 96: 2289-95. 10.1210/jc.2011-1109TableBrierleyJD.Update on external beam radiation therapy in thyroid cancerJ Clin Endocrinol Metab20119622899510.1210/jc.2011-1109TableOpen DOISearch in Google Scholar

25Besic N, Auersperg M, Gazic B, Dremelj M, Zagar I. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study. Thyroid 2012; 22: 131-7. 10.1089/thy.2011.0243TableBesicNAuerspergMGazicBDremeljMZagarI.Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 studyThyroid201222131710.1089/thy.2011.0243TableOpen DOISearch in Google Scholar

26Besic N, Auersperg M, Dremelj M, Vidergar-Kralj B, Gazic B. Neoadjuvant chemotherapy in 16 patients with locally advanced papillary thyroid carcinoma. Thyroid 2013; 23: 178-84. 10.1089/thy.2012.0194TableBesicNAuerspergMDremeljMVidergar-KraljBGazicB.Neoadjuvant chemotherapy in 16 patients with locally advanced papillary thyroid carcinomaThyroid2013231788410.1089/thy.2012.0194TableOpen DOISearch in Google Scholar

27Besic N, Dremelj M, Schwartzbartl-Pevec A, Gazic B. Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experience. Radiol Oncol 2015; 49: 271-8. 10.1515/raon-2015-0001TableBesicNDremeljMSchwartzbartl-PevecAGazicB.Neoadjuvant chemotherapy in 13 patients with locally advanced poorly differentiated thyroid carcinoma based on Turin proposal - a single institution experienceRadiol Oncol201549271810.1515/raon-2015-0001TableOpen DOISearch in Google Scholar

28Vogrin A, Besic H, Besic N, Music MM. Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms. Radiol Oncol 2016; 50: 269-73. 10.1515/raon-2016-0025VogrinABesicHBesicNMusicMM.Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasmsRadiol Oncol2016502697310.1515/raon-2016-0025502465627679542Open DOISearch in Google Scholar